OTC · Biotechnology

CERo Therapeutics Holdings, Inc. (CERO) Stock

$0.01 -7.69% OTC: CERO Healthcare

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers.

Valuation

MetricValue
Price$0.01
Market Cap$14464
P/E Ratio0.00
P/B Ratio-0.04
P/S Ratio0.00
EPS (TTM)$-22.58
52-Week High$8.90
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE396.51%
ROA-938.74%
ROCE201.25%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity-0.06
Current Ratio0.14

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$0$-3.0M$-3.0M$-15.0M$-18.0M
Net Profit$0$-1.0M$0$-8.0M$-20.0M
EPS$-2.75$-19.73$-2497.20$-6.87$-22.58
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$180.0M$42.0M$5.0M$6.0M$4.0M
Total Liabilities$9.0M$40.0M$47.0M$8.0M$9.0M
Cash$1.0M$42.0M$2.0M$3.0M$2.0M
Borrowings$4.0M$1.0M$2.0M$2.0M$1.0M

Latest News

Delisting of Securities from The Nasdaq Stock Market GlobeNewswire · Jul 10, 2026 CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment GlobeNewswire · Jun 15, 2026 CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial GlobeNewswire · May 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-1.0M$-6.0M$-6.0M$-16.0M
Investing Cash Flow$-179.0M$180.0M$0$0$1.0M
Financing Cash Flow$0$-279.0M$0$-13.0M$0
Net Cash Flow$1.0M$41.0M$-5.0M$-5.0M$-2.0M
Free Cash Flow$-1.0M$-2.0M$-6.0M$-6.0M$-16.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA0.01
FCF Yield-99527.38%
Quick Ratio0.14
Interest Coverage-110.40
Return 1Y-99.86%
Return 3Y-100.00%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BCTXZBriaCell Therapeutics Corp. Warrant $0.10 +8.47% -0.30 $188186 0.00%
BIVI $1.52 +6.29% -0.11 $11.46M 0.00%
ELAB $0.92 +2.21% 0.00 $1.78M 0.00%
GLMD $0.62 +3.67% -0.25 $5.13M 0.00%
LIMNLiminatus Pharma, Inc. Class A Common Stock $0.10 -8.39% -0.27 $2.73M 0.00%

About CERo Therapeutics Holdings, Inc.

CERo Therapeutics Holdings, Inc. is a biotech firm dedicated to pioneering advanced engineered T-cell immunotherapies for the treatment of various cancers. Their leading therapeutic candidate, CER-1236, is an autologous T-cell therapy currently in development, aimed at addressing both blood cancers (hematologic malignancies) and solid tumors. This company was founded in 2021 and is headquartered in South San Francisco, California.

CERo Therapeutics Holdings, Inc. is headquartered in US.

CERo Therapeutics Holdings, Inc. (CERO) stock trades at $0.01 with a market capitalization of $14464. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of -0.04, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.01 and $8.90, and currently trades 99.9% below its 52-week high.

On profitability, CERo Therapeutics Holdings, Inc. generates a return on equity (ROE) of 396.51% — well above the market average, a sign of a high-quality business, return on capital employed of 201.25%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.cero.bio

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides